In today’s competitive environment, meeting planners in the life sciences industries are increasingly required to take on greater responsibilities. No longer relegated to marketing support personnel, meeting planners now play a strategic role. To bolster this transition, most companies employ centralized structures for their meeting planning departments. More than ever before, meeting planners interact with [...]

Outcomes-Based Pharmaceutical Pricing: Meeting Stakeholder
Needs (PH116)
Optimize pricing planning to satisfy customer group needs:
The pricing landscape has changed dramatically over the past decade. In the 1990s and even a few years ago, pricing was almost an afterthought - pricing plans were formed and carried out during ramp-up to product launch; there was less regulatory scrutiny; the [...]

Which companies are poised to dominate the diabetes market? With new classes on the rise, which innovative therapies will make an impact? How will clinical results and safety issues affect drug profitability over the long term?
Veteran analysts answer these questions — and more — by placing critical drug information in a relevant [...]

Strengthen Market Research’s Profile and Impact:
Tightening markets, generic encroachment, slowing revenue streams and frequent clinical failures have left pharmaceutical companies treading carefully in efforts to find the next profitable drug. Companies are now trying to determine the correct markets to enter at the earliest positive clinical signs.
This great emphasis on early informed decisions has [...]

Evolving Medical Information Call Centers through Performance Measurement and Process Improvement (PH124)
Reinvent Your Medical Information Call Centers:
Are your call loads decreasing because customers seek information via new avenues?
Do you face info-sharing competition within your own organization?
What new areas demand medical information expertise?
Evolving Medical Information Call Centers addresses these questions — and more [...]

Comprehensive Forecasts for Neurodegenerative Conditions
The neurodegenerative space is a top-selling pharmaceutical market. Consider these facts:
Sales among all drugs profiled in this report total $18.5 billion and are expected to increase 62% to $29.7 billion by 2012.
The majority of this growth is projected to be in multiple sclerosis, which will increase from a $12.6 [...]

Oncology Roadmap Brand Spending Benchmarks and Market Forecast to 2013 (TA220)
Give Your Team Access to the Most Comprehensive Oncology Forecast Ever Created
Cutting Edge Information’s new report, Oncology Roadmap: Brand Spending Benchmarks and Market Forecast to 2013, explores the fiercely competitive oncology market in a way that no other available forecast can match.
Our experienced analysts have [...]

Ensure brand sales success — make the right investment choices at the right time :
Would you like to take the guesswork out of spending on brand commercialization efforts?
Are you sure when and how much to invest in brand promotional activities, market research, reimbursement efforts and medical affairs initiatives?
Driving Successful Pharma Brands addresses these questions — [...]

Thought Leader Fair Market Value Compensation Benchmarks and Procedures (PH 121)
Thought Leader FMV: Compensation and Procedures
Thought leader management teams face many new challenges in today’s environment. Academic institutions have implemented new regulations limiting or, in some cases, forbidding their faculty’s relationships with drug manufacturers. Individual states continue to call for more transparency of the industry’s [...]

Key Opinion Leaders Relationship Management and Segmentation Data (PH122)
Increase thought leader participation and solidify opinion leader efforts:
Plagued by low thought leader participation?
Do your thought leader recruitment efforts feel scattershot or unproductive?
Do you want to ensure that your documentation processes are fail-proof?
If you answered “yes” to any of the above, Key Opinion Leaders: Relationship Management [...]